Clinical Trials Directory

Trials / Completed

CompletedNCT02463318

The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the gene expression and activity of SIRT1, and forkhead box O3 pathway by means of investigating target genes MnSOD and catalase in multiple sclerosis and healthy subjects. Also, we investigate the effect of melatonin on interaction between SIRT1 activity and target genes MnSOD and catalase in multiple sclerosis and healthy subject .Additionally, we evaluate effect the probable effect of melatonin treatment on gene expression and activity of above-mentioned genes in peripheral blood mononuclear cells of healthy subjects-treated with H2O2.

Conditions

Interventions

TypeNameDescription
DRUGMelatoninMelatonin is used for healthy subjects and multiple sclerosis patients
OTHERHydrogen peroxideHydrogen peroxide is only used for healthy subjects

Timeline

Start date
2012-09-01
Primary completion
2015-06-01
Completion
2015-09-01
First posted
2015-06-04
Last updated
2017-05-02

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02463318. Inclusion in this directory is not an endorsement.